Protein A here to stay according to GE Healthcare
Protein A will keep its key role in therapeutic mAb production but next generation biotherapeutics will see Protein L become increasingly import says GE Healthcare.
Archives for June 24, 2014
GSK confident despite ongoing endotoxin problems at Canadian flu vaccine plant
GSK is confident it can meet Flulaval production targets ahead of this winter’s flu season despite ongoing endotoxin contamination problems at a Canadian plant hit with US FDA warning letter.
Dispatches from BIO
Genzyme offers inside look at Massachusetts plant under consent decree
More than four years after Genzyme was issued a consent decree by the FDA at its biomanufacturing facility in Allston, Massachusetts, and the company is still completing its remediation efforts and will be for the years to come.
Govt-backed cell therapy centre will help UK firms reach market says CTC
A new cell therapy development centre has opened at Guy’s Hospital in London today in the latest stage of a Government-backed effort to establish the UK as a global hub.
Lonza says stem cell reprogramming makes for better preclinical models
Lonza has launched a new stem cell reprogramming and maintenance system that has already been used to support US NIH and pharmaceutical company preclinical drug development projects.